Shield Therapeutics PLC (STX)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
11.00p
Buy
11.50p
-0.50p (-4.26%)
Prices updated at 19 Dec 2025, 16:29 GMT
| Prices minimum 15 mins delay
Prices in GBX
Shield Therapeutics PLC is focused on the development and commercialization of late-stage, hospital-focused pharmaceuticals. It is a specialty pharmaceutical company.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 46.40 |
| 2023 | 30.78 |
| 2022 | 44.70 |
| 2021 | 35.48 |
| 2020 | 86.96 |
| 2019 | 32.55 |
| 2018 | 97.38 |
| 2017 | 75.67 |
| 2016 | 67.11 |
| 2015 | - |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 3.46 |
| 2024 | 1.20 |
| 2023 | 5.71 |
| 2022 | 5.01 |
| 2021 | 18.78 |
| 2020 | 11.19 |
| 2019 | 15.42 |
| 2018 | 34.06 |
| 2017 | 660.97 |
| 2016 | 449.86 |
Price/Forward earnings (YTD)
-74.63
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -51.15 |
| 2023 | -88.29 |
| 2022 | -115.08 |
| 2021 | -50.96 |
| 2020 | -7.80 |
| 2019 | -22.44 |
| 2018 | -3.92 |
| 2017 | -42.22 |
| 2016 | -53.80 |
| 2015 | -1,207.06 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | - |
| 2023 | 3.25 |
| 2022 | 4.07 |
| 2021 | 1.08 |
| 2020 | 1.07 |
| 2019 | 1.13 |
| 2018 | 1.08 |
| 2017 | 1.09 |
| 2016 | 1.08 |
| 2015 | - |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
